AirSculpt Q4 Revenue Misses Estimates, Same-Store Sales Decline
summarizeSummary
AirSculpt Technologies reported preliminary Q4 revenue of $33.40 million, falling short of analyst expectations of $34.51 million, alongside a single-digit dip in same-store sales for December. This financial underperformance follows closely on the heels of the company's announced delay in filing its fiscal year 2025 annual report (Form 10-K) due to inter-company transaction classification issues, creating a concerning financial picture. The revenue miss and declining same-store sales are material for this small-cap company and could exert further downward pressure on the stock, especially given the existing uncertainty. While management noted positive comparable sales in February 2026 and provided Q1 2026 revenue guidance, investors will be focused on the finalized 10-K and any further details on operational improvements.
At the time of this announcement, AIRS was trading at $1.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $115.5M. The 52-week trading range was $1.51 to $12.00. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.